Hubei Guangji Pharmaceutical: 2024 Interim Performance Forecast
Hubei Guangji Pharmaceutical: Announcement of the resolution of the first extraordinary Shareholders' Meeting in 2024.
Hubei Guangji Pharmaceutical: Legal Opinion on Witnessing the 2024 First Extraordinary General Meeting of Shareholders of Hubei Guangji Pharmaceutical Co., Ltd. by Beijing Jing Shi (Wuhan) Law Firm
Hubei Guangji Pharmaceutical: Notice to creditors regarding the reduction of registered capital by repurchasing and canceling restricted stocks.
Hubei Guangji Pharmaceutical: Announcement of Resolutions of the 40th (Interim) Meeting of the 10th Board of Supervisors
Hubei Guangji Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Hubei Guangji Pharmaceutical: Announcement of Resolutions of the 42nd (Interim) Meeting of the 10th Board of Directors
Hubei Guangji Pharmaceutical: Independent Financial Advisory Report of Shanghai Xingong Technology Group Co., Ltd. on matters relating to the repurchase and cancellation of some restricted stocks under the 2021 Restricted Stock Incentive Plan of Hubei Guangji Pharmaceutical Co., Ltd.
Hubei Guangji Pharmaceutical: Legal Opinion of Beijing Jingshi (Wuhan) Law Firm on the Repurchase and Cancellation of Part of the Restricted Stock Incentive Plan of Hubei Guangji Pharmaceutical Co., Ltd. in the 2021 Restricted Stock Incentive Plan
Hubei Guangji Pharmaceutical: Announcement on the proposed guarantee for the holding subsidiary Guangji Pharmaceutical (Mengzhou) Co., Ltd.
Hubei Guangji Pharmaceutical: Announcement on the repurchase and cancellation of some restricted stocks in the 2021 Restricted Stock Incentive Plan
Hubei Guangji Pharmaceutical: Notice on holding the 2024 First Extraordinary General Meeting of Shareholders
Hubei Guangji Pharmaceutical: Beijing Jingshi (Wuhan) Law Firm's witness legal opinion on the 2023 Annual General Meeting of Shareholders of Hubei Guangji Pharmaceutical Co., Ltd.
Hubei Guangji Pharmaceutical: Announcement on the progress of plans to participate in bankruptcy and restructuring investments
Hubei Guangji Pharmaceutical: 000952 Guangji Pharmaceutical Investor Relations Management Information 20240516
Hubei Guangji Pharmaceutical: Notice of abnormal fluctuations in stock trading
Hubei Guangji Pharmaceutical: Announcement on holding results briefings for the first quarter of 2023 and 2024
Hubei Guangji Pharmaceutical: 2023 Annual Report Summary
Hubei Guangji Pharmaceutical: Report on the evaluation report on the performance of accounting firms in 2023 and the report on the performance of supervisory duties by the Audit Committee
Hubei Guangji Pharmaceutical: Annual Verification Report on the Use of Raised Funds
No Data